What does Baker Brothers Investments invest in?
Baker Brothers Investments invests most often at Series F and Series B (45% of the rounds on record).
Baker Brothers Investments highlights
- 01
11 rounds on record
- 02
Mostly Series F and Series B: 45% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Based in
- NEW YORK
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first11 appearances
- 2013
1 round
- Apr
- 2012
1 round
- Oct
- 2011
1 round
- Mar
- 2010
1 round
- Jun
- 2009
4 rounds
- Oct
- Jul
- Apr
- Feb
- 2007
3 rounds
- Aug
- Mar
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
AAAlexandra Ann TooheyChief Financial OfficeriForm ADV
FJFelix James BakerLimited PartneriForm ADV
JCJulian Charles BakerLimited PartneriForm ADV
SLScott Lawrence LessingPresident, Chief Compliance OfficeriForm ADV
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$28Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Baker Bros. Advisors LP
- SEC number
- CRD 158149
Funds on its Form ADV
2 private funds, $22B in gross assets · filed Mar 2024
- Baker Brothers Life Sciences, L.P.Hedge330 investors$20B
- 667, L.P.Hedge9 investors$1.5B
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Synageva BioPharmaBought by Alexion Pharmaceuticals$8.4BMay 2015
An exit counts when it came after the firm's first round in the company. From historical deal records.